Filing Details

Accession Number:
0000899243-15-002780
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-11 11:36:32
Reporting Period:
2015-08-11
Filing Date:
2015-08-11
Accepted Time:
2015-08-11 11:36:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1631650 Aimmune Therapeutics Inc. AIMT Pharmaceutical Preparations (2834) 452748244
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1242126 Mark Mcdade C/O Aimmune Therapeutics, Inc.
8000 Marina Boulevard, Suite 300
Brisbane CA 94005-1884
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Acquisiton 2015-08-11 16,660 $16.00 16,660 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Reporting Person purchased 16,660 shares of Issuer's common stock in connection with the initial public offering at the offering price of $16.00 per share.